What is the current Price Target for the Angion Biomedica Corp stock?

The average Angion Biomedica Corp target price is $23.46. This is 1,147.87% higher than the current stock price. The highest price target is 1,407.98%, the lowest is 437.23%. 5 Analysts have issued a price target Angion Biomedica Corp 2027 .

How high will the Angion Biomedica Corp stock rise?

No reliable answer can be given as to how high the Angion Biomedica Corp stock will rise. The performance of stocks, including the Angion Biomedica Corp stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Angion Biomedica Corp stock today?

The performance of Angion Biomedica Corp stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Angion Biomedica Corp stock fall?

The decline in Angion Biomedica Corp stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Angion Biomedica Corp Forecast, price target & analysts

$1.87

0.53%

Nasdaq, Sep 25, 12:22 pm EDT. Market open.

ISIN

US03476J1079

Symbol

ELTX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Angion Biomedica Corp Target price 2026 - Analyst rating & recommendation

Angion Biomedica Corp Classifications & Recommendation

Buy

80%

Hold

20%

Angion Biomedica Corp Price Target

Target Price	$23.46
Price	$1.88
Potential	1,147.87% register free of charge
Number of Estimates	5

	5 Analysts have issued a price target Angion Biomedica Corp 2027 . The average Angion Biomedica Corp target price is $23.46. This is 1,147.87% register free of charge higher than the current stock price. The highest price target is $28.35 1,407.98% register free of charge , the lowest is $10.10 437.23% register free of charge .
	A rating was issued by 10 analysts: 8 Analysts recommend Angion Biomedica Corp to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Angion Biomedica Corp stock has an average upside potential 2027 of 1,147.87% register free of charge . Most analysts recommend the Angion Biomedica Corp stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
P/E		negative

6 Analysts have issued a Angion Biomedica Corp forecast for earnings per share. The average Angion Biomedica Corp EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2027	$-2.48 22.77% unlock
2028	$-2.75 10.89% unlock
2029	$-4.08 48.36% unlock
2030	$-2.96 27.45% unlock
2031	$-0.31 89.53% unlock
2032	$2.35 858.06% unlock
2033	$5.00 112.77% unlock

Current	-0.96	71.19%
2026	-0.93 3.04% unlock
2027	-0.76 18.28% unlock
2028	-0.68 10.53% unlock
2029	-0.46 32.35% unlock
2030	-0.64 39.13% unlock
2031	-6.14 859.38% unlock
2032	0.80 113.03% unlock
2033	0.38 52.50% unlock

Angion Biomedica Corp...

Current Angion Biomedica Corp Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 18 2026
Jones Trading	Locked ➜ Locked	Locked	Jun 16 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jun 15 2026
B. Riley Securities	Locked ➜ Locked	Locked	Jun 10 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	May 28 2026
Ladenburg Thalmann	Locked ➜ Locked	Locked	Apr 15 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 13 2026

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 18 2026
Locked Jones Trading: Locked ➜ Locked	Jun 16 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Jun 15 2026
Locked B. Riley Securities: Locked ➜ Locked	Jun 10 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	May 28 2026
Locked Ladenburg Thalmann: Locked ➜ Locked	Apr 15 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 13 2026

Discover more stocks with a high price target

NIO ADR 101.75%

Alibaba Group Holding Ltd 70.15%

Rheinmetall 66.12%

Infineon 62.78%

Tencent Holdings Ltd. 56.53%

Adyen 53.79%

TUI 52.57%

Uber Technologies 48.83%

BYD 47.08%

Siemens Energy 46.63%

Adidas 42.38%

Deutsche Telekom 37.89%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now